Kangmei Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600518.SS

Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 0.72%

Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) is 0.72% for the year ending December 31, 2023, a 104.03% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was -17.83%, a -136.15% change year over year.
Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 49.32%, a 152.86% change year over year.
Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was -93.31%, a -1,194.56% change year over year.
Kangmei Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was -7.21%, a -1,507.79% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shanghai Stock Exchange: 600518.SS

Kangmei Pharmaceutical Co., Ltd.

CEO	Mr. Guowei Liu
IPO Date	March 19, 2001
Location	China
Headquarters	East side of Jieshen Road
Employees	4,409
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.

Key trends

Past 5 years